Targeting mutant p53 in cancer: the latest insights

被引：19

作者：

Di Agostino, Silvia ^{[1
]}

Fontemaggi, Giulia ^{[1
]}

Strano, Sabrina ^{[1
]}

Blandino, Giovanni ^{[1
]}

D'Orazi, Gabriella ^{[2
,3
]}

机构：

[1] IRCCS Regina Elena Natl Canc Inst, Dept Res Diag & Innovat Technol, Oncogen & Epigenet Unit, I-00144 Rome, Italy

[2] Univ G DAnnunzio, Dept Med Sci, I-66013 Chieti, Italy

[3] IRCCS Regina Elena Natl Canc Inst, Dept Res Adv Diagnost & Innovat Technol, Unit Cellular Networks & Mol Therapeut Targets, I-00144 Rome, Italy

来源：

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 2019年 / 38卷 / 1期

关键词：

p53; Li-Fraumeni; Small molecules; Mutant p53 reactivation; Exosomes; miRNA; Cancer-associated fibroblasts;

D O I：

10.1186/s13046-019-1302-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This commentary wishes to highlight the latest discoveries in the mutant p53 field that have been discussed in the 8th p53 Mutant Workshop 2019, held in Lyon. TP53 mutant (mutp53) proteins are involved in the pathogenesis of most human cancers. Mutp53 proteins not only lose wild-typ53 function but, in some circumstances, may acquire novel oncogenic functions, namely gain-of-function (GOF), which lead to aberrant cell proliferation, chemoresistance, disruption of tissue architecture, migration, invasion and metastasis. Decoding the TP53 mutational spectrum and mutp53 interaction with additional transcription factors will therefore help to developing and testing novel and hopefully more efficient combinatorial therapeutic approaches.

引用

页数：3

共 50 条

[1] Targeting mutant p53 in cancer: the latest insights
Silvia Di Agostino
Giulia Fontemaggi
Sabrina Strano
Giovanni Blandino
Gabriella D’Orazi
[J]. Journal of Experimental & Clinical Cancer Research, 38
[2] Structural and Drug Targeting Insights on Mutant p53
Gomes, Ana Sara
Ramos, Helena
Inga, Alberto
Sousa, Emilia
Saraiva, Lucilia
[J]. CANCERS, 2021, 13 (13)
[3] Targeting mutant p53 for cancer therapy
Oren, Moshe
Tal, Perry
Rotter, Varda
[J]. AGING-US, 2016, 8 (06): : 1159 - 1160
[4] Targeting mutant p53 stabilization for cancer therapy
Wang, Jiajian
Liu, Wenjun
Zhang, Lanqing
Zhang, Jihong
[J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
[5] Targeting mutant p53 for efficient cancer therapy
Vladimir J. N. Bykov
Sofi E. Eriksson
Julie Bianchi
Klas G. Wiman
[J]. Nature Reviews Cancer, 2018, 18 : 89 - 102
[6] Targeting mutant p53 for efficient cancer therapy
Bykov, Vladimir J. N.
Eriksson, Sofi E.
Bianchi, Julie
Wiman, Klas G.
[J]. NATURE REVIEWS CANCER, 2018, 18 (02) : 89 - 102
[7] Targeting Oncogenic Mutant p53 for Cancer Therapy
Parrales, Alejandro
Iwakuma, Tomoo
[J]. FRONTIERS IN ONCOLOGY, 2015, 5
[8] Pharmacological targeting of mutant p53
Kogan, Samuel
Carpizo, Darren
[J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 (06) : 698 - 706
[9] Targeting the mutant p53 secretome
Sehgal, Kartik
Barbie, David A.
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (01):
[10] Cancer immunotherapy: targeting tumors expressing mutant p53
Solomon, Beka
[J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S62 - S62

← 1 2 3 4 5 →